The headline numbers for Synopsys (SNPS) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Synopsys (SNPS) came out with quarterly earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $3.56 per share a year ago.
Synopsys forecast second-quarter revenue above Wall Street estimates on Wednesday, boosted by growing demand for its software used in designing chips.
Synopsys, Inc. SNPS will release its financial results for the first quarter fiscal year 2025, after the closing bell, on Wednesday, Feb. 26, 2025.
SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform.
Get a deeper insight into the potential performance of Synopsys (SNPS) for the quarter ended January 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
In the closing of the recent trading day, Synopsys (SNPS) stood at $493.97, denoting a -1.4% change from the preceding trading day.
Synopsys (SNPS) closed at $522.53 in the latest trading session, marking a -1.09% move from the prior day.
None of these three stocks are conventionally cheap, but they all have huge growth potential from megatrends already in place, making them attractive stocks for investors to buy for the long term. Here's why electronic design automation (EDA) company Synopsys (SNPS 3.65%), design and product management software company PTC (PTC 0.82%), and advanced composite materials company Hexcel (HXL -1.09%) are stocks worth taking long-term positions on.
Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
With the CHIPS Act, rocketship growth in AI and a long trend of automation, companies like Synopsys ($SNPS) are getting unprecedented investor attention. On the latest episode of After Earnings, CFO Shelagh Glaser joined Ann Berry to discuss: • Source of record revenue growth to $6B in 2024 • The $35B acquisition of $ANSS + partnerships with $NVDA, $AMZN, and $TSM • Executing on AI-driven growth in 2025 $SNPS After Earnings is brought to you by Stakeholder Labs and Morning Brew.